Key statistics
On Thursday, 10X Genomics Inc (TXG:NSQ) closed at 13.29, 2.63% above its 52-week low of 12.95, set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.30 |
---|---|
High | 13.51 |
Low | 13.02 |
Bid | 13.15 |
Offer | 13.70 |
Previous close | 13.32 |
Average volume | 2.10m |
---|---|
Shares outstanding | 121.05m |
Free float | 103.97m |
P/E (TTM) | -- |
Market cap | 1.61bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- 10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
- TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
- 10x Genomics Reports Third Quarter 2024 Financial Results
- 10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
- 10x Genomics Announces Preliminary Select Third Quarter 2024 Results
- 10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
More ▼